---
title: "Bayer's Q1 Profit Surpasses Expectations Due to Strong Crop Science Performance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286044370.md"
description: "Bayer, the chemical giant, reported first-quarter profits that exceeded expectations, primarily driven by the robust performance of its Crop Science division. According to Jin10, Bayer announced on Tuesday that its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose to 4.45 billion euros (approximately $5.2 billion). This figure surpassed the widely anticipated 3.9 billion euros. The company confirmed its full-year outlook, adjusted for currency effects."
datetime: "2026-05-12T06:07:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286044370.md)
  - [en](https://longbridge.com/en/news/286044370.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286044370.md)
---

# Bayer's Q1 Profit Surpasses Expectations Due to Strong Crop Science Performance

Bayer, the chemical giant, reported first-quarter profits that exceeded expectations, primarily driven by the robust performance of its Crop Science division. According to Jin10, Bayer announced on Tuesday that its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose to 4.45 billion euros (approximately $5.2 billion). This figure surpassed the widely anticipated 3.9 billion euros. The company confirmed its full-year outlook, adjusted for currency effects.

### Related Stocks

- [BAYZF.US](https://longbridge.com/en/quote/BAYZF.US.md)
- [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md)
- [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md)

## Related News & Research

- [Short Interest in Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Increases By 94.9%](https://longbridge.com/en/news/296026963.md)
- [Bayer says China accepts aflibercept 8 mg filing for retinal vein occlusion macular edema review](https://longbridge.com/en/news/295753151.md)
- [BAYN: Q2 2026 delivered solid sales and EBITDA growth, but free cash flow was impacted by litigation](https://longbridge.com/en/news/294773093.md)
- [Bayer forms new Ruveon business for Roundup in US after legal win](https://longbridge.com/en/news/291511128.md)
- [Bayer Swings to Net Profit on Smaller Litigation Charges](https://longbridge.com/en/news/294778020.md)